This review assesses the current position of desflurane and sevoflurane, two new volatile anaesthetic agents. Sevoflurane is currently licensed for clinical use in Japan. Desflurane is undergoing phase 2/3 clinical trials in Europe and the USA. The properties of the agents are reviewed and their potential role in the future is discussed.